Experiment 1324172
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Nigella sativa (RANUNCULACEAE) |
| Citation | SALIMZADEH,A: GHOURCHIAN,A: CHOOPANI,R: HAJIMEHDIPOOR,H: KAMALINEJAD,M: ABOLHASANI,M:. (2017). EFFECT OF AN ORALLY FORMULATED PROCESSED BLACK CUMIN, FROM IRANIAN TRADITIONAL MEDICINE PHARMACOPOEIA, IN RELIEVING SYMPTOMS OF KNEE OSTEOARTHRITIS: A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND AND PLACEBO-CONTROLLED CLINICAL TRIAL. 20() |
| Amount utilized | |
| Compound isolated | |
| Disease | A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, AND PLACEBO-CONTROLLED CLINICAL TRIAL TO INVESTIGATE BLACK CUMIN SEEDS ARE USEFUL IN ALLEVIATING THE SYMPTOMS OF KNEE OSTEOARTHRITIS. AMERICAN COLLEGE OF RHEUMATOLOGY CLINICAL CRITERIA WERE THE BASIS OF DIAGNOSIS, WHILE THE KNEE INJURY AND OSTEOARTHRITIS OUTCOME SCORE (KOOS) QUESTIONNAIRE WAS CONSIDERED AS THE MAIN OUTCOME MEASURE. ONE HUNDRED AND TEN ELIGIBLE PATIENTS WERE ASSIGNED TO RECEIVE A PLACEBO OR AN ACTIVE INTERVENTION (2 G/DAY OF PROCESSED N. SATIVA SEED POWDER IN DIVIDED DOSES). ACETAMINOPHEN TABLETS WERE THE RESCUE MEDICINE. FINALLY, 40 PATIENTS IN THE PLACEBO GROUP AND 37 PATIENTS IN THE ACTIVE GROUP COMPLETED THE TRIAL AND WERE INCLUDED IN THE STATISTICAL ANALYSIS. RESULTS: BOTH COHORTS DEMONSTRATED STATISTICALLY SIGNIFICANT WITHIN-GROUP DIFFERENCES (P < 0.05) IN SOME SUBSCALES THAT WERE MORE PROMINENT IN THE ACTIVE GROUP WITHOUT ANY CONSIDERABLE ADVERSE EFFECTS. NEVERTHELESS, KOOS SCORE RESULTS AND THE MEAN NUMBER OF ACETAMINOPHEN TABLETS USED BY PATIENTS SHOWED NO STATISTICALLY SIGNIFICANT BETWEEN-GROUP DIFFERENCES. |
| Dose amount | 2 GM |
| Number | 3 |
| Qualitative result | EQUIVOCAL |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Extract | SEEDS |